News Blog
A Paradigm Shift to Realize Intelligent Clinical Trial Oversight
The usual approach of adding technology and headcount to manage today’s clinical trials is not sustainable or scalable. In this webinar, Nick Dyer (CEO, Catalyst Clinical Research) discusses the challenges his team has experienced with complex early phase oncology...
COVID-19 Impact on Clinical Trials
We have all become well acquainted with the overwhelming sense of unpredictability that has cast a shadow on our world from the growing spread of COVID-19. Challenges have arisen from quarantines, site closures, travel limitations, interruptions to supply chains, and...
Catalyst Response to COVID-19
To our valued customers and colleagues: In the wake of the COVID-10 crisis, we have listened to understand the impact that COVID-19 is having on the BioPharma, Medical Device and CRO industries, and beyond. We share our deepest sympathy for the individuals and...
Rare Disease Day 2020
In advance and support of Rare Disease Day, we've been featuring rare diseases throughout the week to bring awareness to these uncommon, yet impactful illnesses. These features included Rett Syndrome, Schwartz Jampel Syndrome, Allan-Herndon-Dudley Syndrome and Noonan...
A Spotlight on Noonan Syndrome
In advance and support of Rare Disease Day taking place this Saturday, February 29, we will continuing featuring rare diseases throughout the week to bring awareness to these uncommon, yet impactful illnesses. NOONAN SYNDROME (NS) is a multisystem disorder...
A Spotlight on Allan-Herndon-Dudley
In advance and support of Rare Disease Day taking place this Saturday, February 29, we will continue featuring rare diseases throughout the week to bring awareness to these uncommon, yet impactful illnesses. Those living with rare diseases often experience...
